Sponsor:
Wake Forest University Health Sciences
Code:
NCT06709404
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Telemedicine
Survey administration
Electronic health record review
Best Practice
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06709404
Start date
Jan 31, 2025
Status verified date
Mar, 2026
Completion date
Mar, 2028
Anticipated
Primary completion date
Mar, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Group 1 (Telehealth intervention)
active comparator: Group 2 (Usual Care)
Interventions
Telemedicine
Survey administration
Electronic health record review
Best Practice
Primary outcome measure
Central contacts
Locations
Wake Forest Baptist Comprehensive Cancer Center
Recruiting
Winston-Salem, North Carolina, United States, 27157
Principal Investigator:
Katie Duckworth, PhD
Sponsor
Wake Forest University Health Sciences
Last update posted
Apr 13, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2026-04-13.